Member Info for mazik

New here I will keep topping up as music streaming is here for the future,and social media like tick tock is being valued in millions, Trillion , Roxi and music streaming could value Billion in 2021. IMO

Fig ,
Great summary A lot to look forward in the coming days and weeks..Happy Xmas all..

The optimisation of production and loading of Nuvec® as a delivery technology platform for nucleic ac
· Successful transfection in vitro of HEK 293T cells with Nuvec® loaded with the Coronavirus DNA Plasmid
· Move to full in vivo study with the Coronavirus and other DNA plasmids with measurement of production of antibodies
· Research Collaboration Agreement with Nanomerics Limited out of UCL's School of Pharmacy
· Result from Ardena as technology transfer and manufacturing partner
End of year update of phase 3 result from Evotec regarding oral application

Short termers who kept the lid due to their shares bought during placing..now we look forward for 10 plus

20p on New Year looks likely, N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec(R) as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. GLA

N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec(R) as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre-clinical and clinical programmes, N4 Pharma will seek to receive up-front payments, milestone payments and ultimately royalty payments once products reach the market. We await 3rd phase result from evotec and potential partner news and we await development , expect £50m capitalisation on initial news

I have topped 28,9k to my son's Xmas box GLA , 10p today

This should move up to pre Xmas 10p

Well funded for the next phase;-) update from Evotec result of phase 3 on oral vaccine using Nuvec
the extension of the formulation and current stability work covering DNA and mRNA formulations;
·research on and evaluation of an additional asset to add to the Company portfolio with potential partner, looking
to a rerate in progress as Variant will open the need for its technology...

Fig , now the importance of N4p is greater than ever before..and oral delivery system an opportunity cannot be missed.Because of the new variant will cause havoc to UK, Holland and Belgium I revise that N4p will hit 20p before an update IMO.

9.5

Leister agree with you, here only patience will pay..with news today of SNG FDA approval, it gives bright lights for n4p with or without vaccine nuvec will be required...holding for partnership and update from all the collaboration going on..imo

sell off and have a good xmas :-) instead of making a statement from your @rse....its under 4p, its all accounted for...whats here "no good" go have your shushi instead of turkey :-)

At 30 November 2020, the Company had net free cash(1) of $87 million. Lancaster producing 12,000 to 14,000 Boed...

thisisawesome,
Thanks for your feedback, did not follow my instinct with ggp and Eua, feel there is a lot of future with 7dig...GLA

Bought in here , I am new with this share having bought last week joined thhe -50% club. Can anyone let me know if Roxi is part of 7Dig? Streaming music and live concerts will be part of the future considering the enormous success Richard Branson had in late 70's . Selling Indies to a massive Virgin records building a multi billion revenues selling to EMI for just under Billion,rest is history.

Anya got my concern out yesterday regarding Evotec, we expect lot of news in front of us including Partnership..strong feeling we might be on the background talking with Astra Zeneca to consider Nuvec for their rollout of their vaccinein March..IMO
If selected a Billion £ capitalisation will be a small change for competitors.

Rollout of nucleic acid-based therapies is hindered by the need to
store the vaccine at ultra-low temperatures. Pfizer’s mRNA based COVID-19 vaccine
requires storage at -70 °C. Initial studies have demonstrated that Nuvec®, loaded with
pDNA, can be dried, stored at room temperature and reconstituted without any
degradation of the pDNA payload. The formulation is now being stored over different
periods of time, after which it will be reconstituted and tested in vitro to evaluate if cell
transfection (the ability to introduce the pDNA into the target cell) has been maintained.
The ability of Nuvec® to be stored at room temperature without affecting its
effectiveness would be of significant interest to developers of nucleic acid-based
treatments

N4p plan for follow on studies and more product focussed experiments as we move towards collaborations." The famous words from Nigel, hopefully sooner than later..

Summers take the dog for a walk we might see it touching 9p, lol! i Should myself beautiful out there